Liquid Biopsy - Global Market Outlook (2016-2022)

Liquid Biopsy - Global Market Outlook (2016-2022)

  • Published: October 2016
  • ID: SMRC16004

According to Stratistics MRC, the Global Liquid Biopsy market is expected to grow from $0.63 billion in 2015 to reach $2.93 billion by 2022 with a CAGR of 24.6%. Increasing research & developments and clinical trials for diagnostics, and technological developments are some of the factors driving the market growth. Moreover, growing prevalence of cancer, increasing awareness about liquid biopsy are the factors fostering the market growth. On the other hand, higher costs and complex regulations are restraining the market growth.

The circulating tumor cells leads the market globally with the biggest market share and is expected to grow with a high CAGR during the forecast period. By cancer type, lung cancer segment is expected to witness high growth rate during the forecast period. North America emerged as the major revenue generating region in the global market due to innovative technological developments, and increasing incidence of cancer rates in the Canada and U.S. Asia Pacific and Latin America are expected to witness high growth rate during the forecast period.

Some of the key players in global liquid biopsy market include Adaptive Biotechnologies, Biocept, Inc., Bio-Rad Laboratories Inc., Guardant Health Inc., Fraunhofer-Gesellschaft, F. Hoffmann-La Roche AG, Epic Sciences, Cynvenio, Illumina Inc., Qiagen, Personal Genome Diagnostics, NeoGenomics Laboratories, Myriad Genetics, Trovagene Inc., RainDance Technologies, MDX Health SA, and Janssen Diagnostics, LLC. 

Sample Types Covered:
• Urine
• Blood
• Others
o CSF
o Plasma
o Saliva

Cancer Types Covered:
• Gastrointestinal Cancer
• Colorectal Cancer
• Breast Cancer
• Leukemia
• Prostate Cancer
• Lung Cancer
• Liver Cancer
• Other Cancers
o Ovarian Cancer
o Melanoma
o Bladder Cancer

Circulating Biomarkers Covered:
• Extracellular Vesicles (EVs)
• Circulating Tumor DNA (ctDNA)
• Exosomes
• Circulating Tumor Cells (CTCs)
• Other Biomarkers
o Circulating RNA and Protein

Products and Services Covered:
• Services and Software
• Reagents
• Instruments

End Users Covered:
• Hospital and Physician Laboratories
• Diagnostic Centers
• Academic & Research Centers
• Others End User
o Small Molecular Laboratories
o Public Health Laboratories
o Pathology Laboratories

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain     
o Rest of Europe 
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary 
   
2 Preface
  
 2.1 Abstract 
 2.2 Stake Holders
 2.3 Research Scope
 2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
 2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions
   
3 Market Trend Analysis

 3.1 Introduction
 3.2 Drivers 
 3.3 Restraints
 3.4 Opportunities
 3.5 Threats 
 3.6 Product Analysis
 3.7 End User Analysis
 3.8 Emerging Markets
   
4 Porters Five Force Analysis
 4.1 Bargaining power of suppliers
 4.2 Bargaining power of buyers
 4.3 Threat of substitutes
 4.4 Threat of new entrants
 4.5 Competitive rivalry
   
5 Global Liquid Biopsy Market Analysis, By Sample Type
 5.1 Introduction
 5.2 Urine 
 5.3 Blood 
 5.4 Others 
  5.4.1 CSF
  5.4.2 Plasma
  5.4.3 Saliva
   
6 Global Liquid Biopsy Market, By Cancer Type
 6.1 Introduction
 6.2 Gastrointestinal Cancer
 6.3 Colorectal Cancer
 6.4 Breast Cancer
 6.5 Leukemia
 6.6 Prostate Cancer
 6.7 Lung Cancer
 6.8 Liver Cancer
 6.9 Other Cancers
  6.9.1 Ovarian Cancer
  6.9.2 Melanoma
  6.9.3 Bladder Cancer
   
7 Global Liquid Biopsy Market, by Circulating Biomarkers
 7.1 Introduction
 7.2 Extracellular Vesicles (EVs)
 7.3 Circulating Tumor DNA (ctDNA)
 7.4 Exosomes
 7.5 Circulating Tumor Cells (CTCs)
 7.6 Other Biomarkers
  7.6.1 Circulating RNA and Protein
   
8 Global Liquid Biopsy Market, by Products and Services

 8.1 Introduction
 8.2 Services and Software
 8.3 Reagents 
 8.4 Instruments
   
9 Global Liquid Biopsy Market, by End User
 9.1 Introduction
 9.2 Hospital and Physician Laboratories
 9.3 Diagnostic Centers
 9.4 Academic & Research Centers
 9.5 Others End User
  9.5.1 Small Molecular Laboratories
  9.5.2 Public Health Laboratories
  9.5.3 Pathology Laboratories
   
10 Global Liquid Biopsy Market, By Geography

 10.1 North America
  10.1.1 US
  10.1.2 Canada
  10.1.3 Mexico
 10.2 Europe 
  10.2.1 Germany
  10.2.2 France
  10.2.3 Italy
  10.2.4 UK
  10.2.5 Spain
  10.2.6 Rest of Europe
 10.3 Asia Pacific
  10.3.1 Japan
  10.3.2 China
  10.3.3 India
  10.3.4 Australia
  10.3.5 New Zealand
  10.3.6 Rest of Asia Pacific
 10.4 Rest of the World
  10.4.1 Middle East
  10.4.2 Brazil
  10.4.3 Argentina
  10.4.4 South Africa
  10.4.5 Egypt
   
11 Key Developments 
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
 11.2 Acquisitions & Mergers
 11.3 New Product Launch
 11.4 Expansions
 11.5 Other Key Strategies
   
12 Company Profiling 
 12.1 Adaptive Biotechnologies
 12.2 Biocept, Inc. 
 12.3 Bio-Rad Laboratories Inc.
 12.4 Guardant Health Inc.
 12.5 Fraunhofer-Gesellschaft
 12.6 F. Hoffmann-La Roche AG
 12.7 Epic Sciences
 12.8 Cynvenio 
 12.9 Illumina Inc.
 12.10 Qiagen  
 12.11 Personal Genome Diagnostics
 12.12 NeoGenomics Laboratories
 12.13 Myriad Genetics 
 12.14 Trovagene Inc.
 12.15 RainDance Technologies
 12.16 MDX Health SA
 12.17 Janssen Diagnostics, LLC.


List of Tables  
1 Global Liquid Biopsy Market, By Region (2013-2022) ($MN)
2 Global Liquid Biopsy Market, By Sample Type (2013-2022) ($MN)
3 Global Liquid Biopsy Market, By Urine (2013-2022) ($MN)
4 Global Liquid Biopsy Market, By Blood (2013-2022) ($MN)
5 Global Liquid Biopsy Market, By Others (2013-2022) ($MN)
6 Global Liquid Biopsy Market, By CSF (2013-2022) ($MN)
7 Global Liquid Biopsy Market, By Plasma (2013-2022) ($MN)
8 Global Liquid Biopsy Market, By Saliva (2013-2022) ($MN)
9 Global Liquid Biopsy Market, By Cancer Type (2013-2022) ($MN)
10 Global Liquid Biopsy Market, By Gastrointestinal Cancer (2013-2022) ($MN)
11 Global Liquid Biopsy Market, By Colorectal Cancer (2013-2022) ($MN)
12 Global Liquid Biopsy Market, By Breast Cancer (2013-2022) ($MN)
13 Global Liquid Biopsy Market, By Leukemia (2013-2022) ($MN)
14 Global Liquid Biopsy Market, By Prostate Cancer (2013-2022) ($MN)
15 Global Liquid Biopsy Market, By Lung Cancer (2013-2022) ($MN)
16 Global Liquid Biopsy Market, By Liver Cancer (2013-2022) ($MN)
17 Global Liquid Biopsy Market, By Other Cancers (2013-2022) ($MN)
18 Global Liquid Biopsy Market, By Ovarian Cancer (2013-2022) ($MN)
19 Global Liquid Biopsy Market, By Melanoma (2013-2022) ($MN)
20 Global Liquid Biopsy Market, By Bladder Cancer (2013-2022) ($MN)
21 Global Liquid Biopsy Market, By Circulating Biomarkers (2013-2022) ($MN)
22 Global Liquid Biopsy Market, By Extracellular Vesicles (EVs) (2013-2022) ($MN)
23 Global Liquid Biopsy Market, By Circulating Tumor DNA (ctDNA) (2013-2022) ($MN)
24 Global Liquid Biopsy Market, By Exosomes (2013-2022) ($MN)
25 Global Liquid Biopsy Market, By Circulating Tumor Cells (CTCs) (2013-2022) ($MN)
26 Global Liquid Biopsy Market, By Other Biomarkers (2013-2022) ($MN)
27 Global Liquid Biopsy Market, By Circulating RNA and Protein (2013-2022) ($MN)
28 Global Liquid Biopsy Market, By Products and Services (2013-2022) ($MN)
29 Global Liquid Biopsy Market, By Services and Software (2013-2022) ($MN)
30 Global Liquid Biopsy Market, By Reagents (2013-2022) ($MN)
31 Global Liquid Biopsy Market, By Instruments (2013-2022) ($MN)
32 Global Liquid Biopsy Market, By End User (2013-2022) ($MN)
33 Global Liquid Biopsy Market, By Hospital and Physician Laboratories (2013-2022) ($MN)
34 Global Liquid Biopsy Market, By Diagnostic Centers (2013-2022) ($MN)
35 Global Liquid Biopsy Market, By Academic & Research Centers (2013-2022) ($MN)
36 Global Liquid Biopsy Market, By Others End User (2013-2022) ($MN)
37 Global Liquid Biopsy Market, By Small Molecular Laboratories (2013-2022) ($MN)
38 Global Liquid Biopsy Market, By Public Health Laboratories (2013-2022) ($MN)
39 Global Liquid Biopsy Market, By Pathology Laboratories (2013-2022) ($MN)
40 North America Liquid Biopsy Market, By Country (2013-2022) ($MN)
41 North America Liquid Biopsy Market, By Sample Type (2013-2022) ($MN)
42 North America Liquid Biopsy Market, By Urine (2013-2022) ($MN)
43 North America Liquid Biopsy Market, By Blood (2013-2022) ($MN)
44 North America Liquid Biopsy Market, By Others (2013-2022) ($MN)
45 North America Liquid Biopsy Market, By CSF (2013-2022) ($MN)
46 North America Liquid Biopsy Market, By Plasma (2013-2022) ($MN)
47 North America Liquid Biopsy Market, By Saliva (2013-2022) ($MN)
48 North America Liquid Biopsy Market, By Cancer Type (2013-2022) ($MN)
49 North America Liquid Biopsy Market, By Gastrointestinal Cancer (2013-2022) ($MN)
50 North America Liquid Biopsy Market, By Colorectal Cancer (2013-2022) ($MN)
51 North America Liquid Biopsy Market, By Breast Cancer (2013-2022) ($MN)
52 North America Liquid Biopsy Market, By Leukemia (2013-2022) ($MN)
53 North America Liquid Biopsy Market, By Prostate Cancer (2013-2022) ($MN)
54 North America Liquid Biopsy Market, By Lung Cancer (2013-2022) ($MN)
55 North America Liquid Biopsy Market, By Liver Cancer (2013-2022) ($MN)
56 North America Liquid Biopsy Market, By Other Cancers (2013-2022) ($MN)
57 North America Liquid Biopsy Market, By Ovarian Cancer (2013-2022) ($MN)
58 North America Liquid Biopsy Market, By Melanoma (2013-2022) ($MN)
59 North America Liquid Biopsy Market, By Bladder Cancer (2013-2022) ($MN)
60 North America Liquid Biopsy Market, By Circulating Biomarkers (2013-2022) ($MN)
61 North America Liquid Biopsy Market, By Extracellular Vesicles (EVs) (2013-2022) ($MN)
62 North America Liquid Biopsy Market, By Circulating Tumor DNA (ctDNA) (2013-2022) ($MN)
63 North America Liquid Biopsy Market, By Exosomes (2013-2022) ($MN)
64 North America Liquid Biopsy Market, By Circulating Tumor Cells (CTCs) (2013-2022) ($MN)
65 North America Liquid Biopsy Market, By Other Biomarkers (2013-2022) ($MN)
66 North America Liquid Biopsy Market, By Circulating RNA and Protein (2013-2022) ($MN)
67 North America Liquid Biopsy Market, By Products and Services (2013-2022) ($MN)
68 North America Liquid Biopsy Market, By Services and Software (2013-2022) ($MN)
69 North America Liquid Biopsy Market, By Reagents (2013-2022) ($MN)
70 North America Liquid Biopsy Market, By Instruments (2013-2022) ($MN)
71 North America Liquid Biopsy Market, By End User (2013-2022) ($MN)
72 North America Liquid Biopsy Market, By Hospital and Physician Laboratories (2013-2022) ($MN)
73 North America Liquid Biopsy Market, By Diagnostic Centers (2013-2022) ($MN)
74 North America Liquid Biopsy Market, By Academic & Research Centers (2013-2022) ($MN)
75 North America Liquid Biopsy Market, By Others End User (2013-2022) ($MN)
76 North America Liquid Biopsy Market, By Small Molecular Laboratories (2013-2022) ($MN)
77 North America Liquid Biopsy Market, By Public Health Laboratories (2013-2022) ($MN)
78 North America Liquid Biopsy Market, By Pathology Laboratories (2013-2022) ($MN)
79 Europe Liquid Biopsy Market, By Country (2013-2022) ($MN)
80 Europe Liquid Biopsy Market, By Sample Type (2013-2022) ($MN)
81 Europe Liquid Biopsy Market, By Urine (2013-2022) ($MN)
82 Europe Liquid Biopsy Market, By Blood (2013-2022) ($MN)
83 Europe Liquid Biopsy Market, By Others (2013-2022) ($MN)
84 Europe Liquid Biopsy Market, By CSF (2013-2022) ($MN)
85 Europe Liquid Biopsy Market, By Plasma (2013-2022) ($MN)
86 Europe Liquid Biopsy Market, By Saliva (2013-2022) ($MN)
87 Europe Liquid Biopsy Market, By Cancer Type (2013-2022) ($MN)
88 Europe Liquid Biopsy Market, By Gastrointestinal Cancer (2013-2022) ($MN)
89 Europe Liquid Biopsy Market, By Colorectal Cancer (2013-2022) ($MN)
90 Europe Liquid Biopsy Market, By Breast Cancer (2013-2022) ($MN)
91 Europe Liquid Biopsy Market, By Leukemia (2013-2022) ($MN)
92 Europe Liquid Biopsy Market, By Prostate Cancer (2013-2022) ($MN)
93 Europe Liquid Biopsy Market, By Lung Cancer (2013-2022) ($MN)
94 Europe Liquid Biopsy Market, By Liver Cancer (2013-2022) ($MN)
95 Europe Liquid Biopsy Market, By Other Cancers (2013-2022) ($MN)
96 Europe Liquid Biopsy Market, By Ovarian Cancer (2013-2022) ($MN)
97 Europe Liquid Biopsy Market, By Melanoma (2013-2022) ($MN)
98 Europe Liquid Biopsy Market, By Bladder Cancer (2013-2022) ($MN)
99 Europe Liquid Biopsy Market, By Circulating Biomarkers (2013-2022) ($MN)
100 Europe Liquid Biopsy Market, By Extracellular Vesicles (EVs) (2013-2022) ($MN)
101 Europe Liquid Biopsy Market, By Circulating Tumor DNA (ctDNA) (2013-2022) ($MN)
102 Europe Liquid Biopsy Market, By Exosomes (2013-2022) ($MN)
103 Europe Liquid Biopsy Market, By Circulating Tumor Cells (CTCs) (2013-2022) ($MN)
104 Europe Liquid Biopsy Market, By Other Biomarkers (2013-2022) ($MN)
105 Europe Liquid Biopsy Market, By Circulating RNA and Protein (2013-2022) ($MN)
106 Europe Liquid Biopsy Market, By Products and Services (2013-2022) ($MN)
107 Europe Liquid Biopsy Market, By Services and Software (2013-2022) ($MN)
108 Europe Liquid Biopsy Market, By Reagents (2013-2022) ($MN)
109 Europe Liquid Biopsy Market, By Instruments (2013-2022) ($MN)
110 Europe Liquid Biopsy Market, By End User (2013-2022) ($MN)
111 Europe Liquid Biopsy Market, By Hospital and Physician Laboratories (2013-2022) ($MN)
112 Europe Liquid Biopsy Market, By Diagnostic Centers (2013-2022) ($MN)
113 Europe Liquid Biopsy Market, By Academic & Research Centers (2013-2022) ($MN)
114 Europe Liquid Biopsy Market, By Others End User (2013-2022) ($MN)
115 Europe Liquid Biopsy Market, By Small Molecular Laboratories (2013-2022) ($MN)
116 Europe Liquid Biopsy Market, By Public Health Laboratories (2013-2022) ($MN)
117 Europe Liquid Biopsy Market, By Pathology Laboratories (2013-2022) ($MN)
118 Asia Pacific Liquid Biopsy Market, By Country (2013-2022) ($MN)
119 Asia Pacific Liquid Biopsy Market, By Sample Type (2013-2022) ($MN)
120 Asia Pacific Liquid Biopsy Market, By Urine (2013-2022) ($MN)
121 Asia Pacific Liquid Biopsy Market, By Blood (2013-2022) ($MN)
122 Asia Pacific Liquid Biopsy Market, By Others (2013-2022) ($MN)
123 Asia Pacific Liquid Biopsy Market, By CSF (2013-2022) ($MN)
124 Asia Pacific Liquid Biopsy Market, By Plasma (2013-2022) ($MN)
125 Asia Pacific Liquid Biopsy Market, By Saliva (2013-2022) ($MN)
126 Asia Pacific Liquid Biopsy Market, By Cancer Type (2013-2022) ($MN)
127 Asia Pacific Liquid Biopsy Market, By Gastrointestinal Cancer (2013-2022) ($MN)
128 Asia Pacific Liquid Biopsy Market, By Colorectal Cancer (2013-2022) ($MN)
129 Asia Pacific Liquid Biopsy Market, By Breast Cancer (2013-2022) ($MN)
130 Asia Pacific Liquid Biopsy Market, By Leukemia (2013-2022) ($MN)
131 Asia Pacific Liquid Biopsy Market, By Prostate Cancer (2013-2022) ($MN)
132 Asia Pacific Liquid Biopsy Market, By Lung Cancer (2013-2022) ($MN)
133 Asia Pacific Liquid Biopsy Market, By Liver Cancer (2013-2022) ($MN)
134 Asia Pacific Liquid Biopsy Market, By Other Cancers (2013-2022) ($MN)
135 Asia Pacific Liquid Biopsy Market, By Ovarian Cancer (2013-2022) ($MN)
136 Asia Pacific Liquid Biopsy Market, By Melanoma (2013-2022) ($MN)
137 Asia Pacific Liquid Biopsy Market, By Bladder Cancer (2013-2022) ($MN)
138 Asia Pacific Liquid Biopsy Market, By Circulating Biomarkers (2013-2022) ($MN)
139 Asia Pacific Liquid Biopsy Market, By Extracellular Vesicles (EVs) (2013-2022) ($MN)
140 Asia Pacific Liquid Biopsy Market, By Circulating Tumor DNA (ctDNA) (2013-2022) ($MN)
141 Asia Pacific Liquid Biopsy Market, By Exosomes (2013-2022) ($MN)
142 Asia Pacific Liquid Biopsy Market, By Circulating Tumor Cells (CTCs) (2013-2022) ($MN)
143 Asia Pacific Liquid Biopsy Market, By Other Biomarkers (2013-2022) ($MN)
144 Asia Pacific Liquid Biopsy Market, By Circulating RNA and Protein (2013-2022) ($MN)
145 Asia Pacific Liquid Biopsy Market, By Products and Services (2013-2022) ($MN)
146 Asia Pacific Liquid Biopsy Market, By Services and Software (2013-2022) ($MN)
147 Asia Pacific Liquid Biopsy Market, By Reagents (2013-2022) ($MN)
148 Asia Pacific Liquid Biopsy Market, By Instruments (2013-2022) ($MN)
149 Asia Pacific Liquid Biopsy Market, By End User (2013-2022) ($MN)
150 Asia Pacific Liquid Biopsy Market, By Hospital and Physician Laboratories (2013-2022) ($MN)
151 Asia Pacific Liquid Biopsy Market, By Diagnostic Centers (2013-2022) ($MN)
152 Asia Pacific Liquid Biopsy Market, By Academic & Research Centers (2013-2022) ($MN)
153 Asia Pacific Liquid Biopsy Market, By Others End User (2013-2022) ($MN)
154 Asia Pacific Liquid Biopsy Market, By Small Molecular Laboratories (2013-2022) ($MN)
155 Asia Pacific Liquid Biopsy Market, By Public Health Laboratories (2013-2022) ($MN)
156 Asia Pacific Liquid Biopsy Market, By Pathology Laboratories (2013-2022) ($MN)
157 RoW Liquid Biopsy Market, By Country (2013-2022) ($MN)
158 RoW Liquid Biopsy Market, By Sample Type (2013-2022) ($MN)
159 RoW Liquid Biopsy Market, By Urine (2013-2022) ($MN)
160 RoW Liquid Biopsy Market, By Blood (2013-2022) ($MN)
161 RoW Liquid Biopsy Market, By Others (2013-2022) ($MN)
162 RoW Liquid Biopsy Market, By CSF (2013-2022) ($MN)
163 RoW Liquid Biopsy Market, By Plasma (2013-2022) ($MN)
164 RoW Liquid Biopsy Market, By Saliva (2013-2022) ($MN)
165 RoW Liquid Biopsy Market, By Cancer Type (2013-2022) ($MN)
166 RoW Liquid Biopsy Market, By Gastrointestinal Cancer (2013-2022) ($MN)
167 RoW Liquid Biopsy Market, By Colorectal Cancer (2013-2022) ($MN)
168 RoW Liquid Biopsy Market, By Breast Cancer (2013-2022) ($MN)
169 RoW Liquid Biopsy Market, By Leukemia (2013-2022) ($MN)
170 RoW Liquid Biopsy Market, By Prostate Cancer (2013-2022) ($MN)
171 RoW Liquid Biopsy Market, By Lung Cancer (2013-2022) ($MN)
172 RoW Liquid Biopsy Market, By Liver Cancer (2013-2022) ($MN)
173 RoW Liquid Biopsy Market, By Other Cancers (2013-2022) ($MN)
174 RoW Liquid Biopsy Market, By Ovarian Cancer (2013-2022) ($MN)
175 RoW Liquid Biopsy Market, By Melanoma (2013-2022) ($MN)
176 RoW Liquid Biopsy Market, By Bladder Cancer (2013-2022) ($MN)
177 RoW Liquid Biopsy Market, By Circulating Biomarkers (2013-2022) ($MN)
178 RoW Liquid Biopsy Market, By Extracellular Vesicles (EVs) (2013-2022) ($MN)
179 RoW Liquid Biopsy Market, By Circulating Tumor DNA (ctDNA) (2013-2022) ($MN)
180 RoW Liquid Biopsy Market, By Exosomes (2013-2022) ($MN)
181 RoW Liquid Biopsy Market, By Circulating Tumor Cells (CTCs) (2013-2022) ($MN)
182 RoW Liquid Biopsy Market, By Other Biomarkers (2013-2022) ($MN)
183 RoW Liquid Biopsy Market, By Circulating RNA and Protein (2013-2022) ($MN)
184 RoW Liquid Biopsy Market, By Products and Services (2013-2022) ($MN)
185 RoW Liquid Biopsy Market, By Services and Software (2013-2022) ($MN)
186 RoW Liquid Biopsy Market, By Reagents (2013-2022) ($MN)
187 RoW Liquid Biopsy Market, By Instruments (2013-2022) ($MN)
188 RoW Liquid Biopsy Market, By End User (2013-2022) ($MN)
189 RoW Liquid Biopsy Market, By Hospital and Physician Laboratories (2013-2022) ($MN)
190 RoW Liquid Biopsy Market, By Diagnostic Centers (2013-2022) ($MN)
191 RoW Liquid Biopsy Market, By Academic & Research Centers (2013-2022) ($MN)
192 RoW Liquid Biopsy Market, By Others End User (2013-2022) ($MN)
193 RoW Liquid Biopsy Market, By Small Molecular Laboratories (2013-2022) ($MN)
194 RoW Liquid Biopsy Market, By Public Health Laboratories (2013-2022) ($MN)
195 RoW Liquid Biopsy Market, By Pathology Laboratories (2013-2022) ($MN)

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials